IRVINE, Calif., May 24 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. today announced that it will present at the Friedman Billings Ramsey 2006 Growth Investor Conference at 9:00 a.m. EDT on Wednesday, May 31, 2006 at the Grand Hyatt Hotel in New York.
ISTA’s President and Chief Executive Officer, Vicente Anido, Jr., Ph.D. will provide an update on the Company’s commercial and clinical progress. To access the live audio broadcast or the subsequent archived recording log onto http://www.istavision.com. Please connect to the website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.
About ISTA
ISTA is a specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products. ISTA’s products and product candidates seek to address serious diseases and conditions of the eye such as dry eye, vitreous hemorrhage, diabetic retinopathy, hyphema, glaucoma, ocular pain and inflammation. Building on this pipeline, ISTA’s goal is to continue its growth as a specialty pharmaceutical company through a combination of its own product development efforts and by acquiring complementary product candidates. For additional information regarding ISTA, please visit ISTA Pharmaceuticals’ Website at http://www.istavision.com.
ISTA Pharmaceuticals, Inc.
CONTACT: Justin Jackson, Media, jjackson@burnsmc.com, or Laura Siino,Investors, lsiino@burnsmc.com, both of Burns McClellan, +1-212-213-0006; orVince Anido, +1-949-788-5311, or vanido@istavision.com, or LaurenSilvernail, +1-949-788-5302, or lsilvernail@istavision.com, both of ISTAPharmaceuticals
Web site: http://www.istavision.com//
